Catalyst Science Discovery Centre appoints director

Widnes, Cheshire-based firm welcomes Stephen Youd-Thomas

Catalyst Science Discovery Centre appoints director
Catalyst Science Discovery Centre, an interactive science centre and museum devoted to chemistry and how the products of chemistry are used in everyday life based in Widnes, Cheshire, UK, has a new director of catalyst, which encompasses the role of ERDF project director.

Stephen Youd-Thomas runs a successful corporate and social responsibility consultancy and was formerly head of social goals at the Co-operative Group.

‘This is a wonderful opportunity to help develop the work of the UK's only science discovery centre with chemistry as its main theme. Catalyst brings chemistry alive for thousands of young people from across the North West and beyond and hopefully this experience will encourage many of them to consider a career in science in the future,’ he said.

Catalyst is an independent charitable trust operated by Catalyst Science Discovery Centre and Museum Trust.

You may also like

Research & Development
Anton Paar launches new UNHT series for next-generation nanoindentation

Anton Paar launches new UNHT series for next-generation nanoindentation

Anton Paar introduces the new UNHT Series, a new generation of nanoindentation systems designed to deliver reliable results, faster workflows, and greater versatility across a wide range of materials
Ingredients
Indena to showcase its integrated European platform for HPAPIs and complex molecules at CPHI Milan 2026

Indena to showcase its integrated European platform for HPAPIs and complex molecules at CPHI Milan 2026

The leading unit CDMO will highlight breakthroughs in ADC payloads, ultra-high containment spray drying, and its strategic QS-21 partnership
Research & Development
Rethinking the route to first-in-human studies

Rethinking the route to first-in-human studies

For sponsors, development activities and fragmented clinical supply can slow the path from candidate selection to first-in-human (FIH) dosing. A more integrated approach can reduce avoidable complexity while preserving the flexibility needed for early clinical programmes
Finance
Ofichem acquires US drug substance CDMO Kinentia Biosciences to expand transatlantic network

Ofichem acquires US drug substance CDMO Kinentia Biosciences to expand transatlantic network

The company has agreed to acquire New York-based Kinentia Biosciences, expanding its US presence and combining Kinentia’s early-stage development expertise with Ofichem’s European drug substance development and GMP manufacturing capabilities
Digital
Charles River and Autolomous launch Apollo Orchestrate LES to digitalise biologics QC testing workflow

Charles River and Autolomous launch Apollo Orchestrate LES to digitalise biologics QC testing workflow

The autoloMATE-powered platform connects sample submission, laboratory execution and review into a single digital workflow across Charles River's North American and European Biologics Testing Solutions sites — replacing paper-based processes to accelerate client results
Media
CPHI Pharma Awards 2026 recognise Touchlight, SeraNovo and Almac among fifteen category winners in Milan

CPHI Pharma Awards 2026 recognise Touchlight, SeraNovo and Almac among fifteen category winners in Milan

Touchlight's dbDNA platform took Innovation Catalyst, SeraNovo's NanoGlass oral formulation won Finished Formulation and Almac Clinical Services claimed Supply Chain Excellence — with BMS's Emma Charles named Woman of the Year
Manufacturing
Patented device reinvents Solid Phase Extraction

Patented device reinvents Solid Phase Extraction

Biotech Fluidics announce SPEedy - a device that provides an effortless way to perform Solid Phase Extraction (SPE) sample preparation procedures without need of an external vacuum and compatible with any adsorption chemistry or eluent composition
Subscribe now